Rep. Peter Welch (D-Vt.) issued the following statement on the conclusion of Special Counsel Robert Mueller’s investigation:
WASHINGTON, DC – Today, the New England Congressional Delegation issued the following statement regarding cuts to Low Income Home Energy Assistance Program (LIHEAP) in New England.
Rep. Peter Welch (D-Vt.) and Rep. Mike Simpson (R-Idaho) today re-introduced bipartisan legislation in the House that requires the Food and Drug Administration (FDA) to take enforcement action against manufacturers labeling non-dairy products as dairy.
WASHINGTON – Rep. Peter Welch (D-Vt.) today spoke on the floor of the House of Representatives in support of a resolution calling for special counsel Robert Mueller’s report to be made available to the American public and to Congress. The resolution is expected to pass the House tomorrow.
WASHINGTON – Sen. Patrick Leahy (D-Vt.), Sen. Bernie Sanders (I-Vt.) and Rep. Peter Welch (D-Vt.) joined House and Senate colleagues in introducing legislation to restore a free and open internet.
Washington, DC – Late yesterday, the U.S. House of Representatives unanimously approved bipartisan legislation introduced by Rep. Peter Welch (D-Vt.) to help schools become more energy efficient in Vermont and across the country.
BURLINGTON, Vt. -- Rep. Peter Welch (D-Vt.) announced today that Rebecca Ellis of Waterbury Center will join his staff on March 25th as state director. She replaces George Twigg, who relocated to Colorado in January.
WASHINGTON - At a hearing of the House Committee on Oversight and Reform this afternoon, Rep. Peter Welch (D-Vt.) questioned Michael Cohen, former attorney to President Donald Trump. During the exchange, Welch asked Cohen about President Trump’s knowledge of a stolen, “massive dump of emails that would damage Hillary Clinton’s campaign” by WikiLeaks.
BURLINGTON – At a press conference today at Community Health Centers of Burlington, Rep.
In The News
President Donald Trump says his decision to buck the advice of America’s closest Muslim allies and recognize Jerusalem as Israel’s capital is part of a broader strategy shift needed to produce a Middle East peace pact.
There are two great threats to American democracy today and neither one are named Trump, said Vermont’s lone-ranger congressman, Peter Francis Welch (D-VT).
“It’s a mess in Washington,” Congressman Peter Welch told a group of Champlain Valley specialty crop farmers who gathered in Middlebury last week to share their wish lists for the 2018 farm bill. But, despite the dysfunction in much of the nation’s capital, the Vermont Democrat said there is still hope because there tends to be bipartisan support to “get a decent farm bill.”
On a visit to Bennington, Rep. Peter Welch echoed recent remarks from Gov. Phil Scott, calling for bipartisan remedies for a polarized nation.
Rep. Peter Welch (D-Vt.) is not mincing words when it comes to Allergan Inc.’s deal with an American Indian tribe geared toward protecting one of the company’s top products.
There's a push to help more parents in Vermont pay for child care.
Friday, Congressman Peter Welch announced legislation he's introduced. It's called the Child Care for Working Families Act and it's meant to expand the access families have to affordable, high-quality child care. Welch says it's a top priority for him to make this a reality for Vermonters.
Vermont Rep. Peter Welch said he believes Republican President Donald Trump wants to ensure there is protected legal status for Dreamers after taking part in a bipartisan meeting with him Wednesday afternoon.
Speaking at the Larner College of Medicine at the University of Vermont on Monday, Congressman Peter Welch said it was critical that Congress find a way to continue DACA— Deferred Action for Childhood Arrivals.
Forty-two Vermonters’ immigration status is uncertain now that President Donald Trump has vowed to end the Deferred Action for Childhood Arrivals program, according to Congressman Peter Welch (D-Vt.).
U.S. House Democrats said on Thursday they were launching an investigation into why prices for Multiple Sclerosis (MS) treatments have nearly quintupled since 2004, and they sent letters requesting information from seven drugmakers.